129 related articles for article (PubMed ID: 38762063)
21. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
22. T-cell receptor repertoire of infiltrating T cells in lachrymal glands, salivary glands and kidneys from alymphoplasia (aly) mutant mice: a new model for Sjögren's syndrome.
Furukawa M; Sakamoto A; Kita Y; Ohishi Y; Matsumura R; Tsubata R; Tsubata T; Iwamoto I; Saito Y; Sumida T
Br J Rheumatol; 1996 Dec; 35(12):1223-30. PubMed ID: 9010048
[TBL] [Abstract][Full Text] [Related]
23. Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction.
Sharma A; Kiripolsky J; Klimatcheva E; Howell A; Fereidouni F; Levenson R; Rothstein TL; Kramer JM
Clin Immunol; 2016 Mar; 164():85-94. PubMed ID: 26826598
[TBL] [Abstract][Full Text] [Related]
24. Single-cell analysis reveals sexually dimorphic repertoires of Interferon-γ and IL-17A producing T cells in salivary glands of Sjögren's syndrome mice.
Wanchoo A; Voigt A; Sukumaran S; Stewart CM; Bhattacharya I; Nguyen CQ
Sci Rep; 2017 Oct; 7(1):12512. PubMed ID: 28970488
[TBL] [Abstract][Full Text] [Related]
25. Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjögren's syndrome.
Sumida T; Iizuka M; Asashima H; Tsuboi H; Matsumoto I
Presse Med; 2012 Sep; 41(9 Pt 2):e461-6. PubMed ID: 22884125
[TBL] [Abstract][Full Text] [Related]
26. Effector mechanism of experimental autoimmune sialadenitis in the mouse model for primary Sjögren's syndrome.
Hayashi Y; Haneji N; Hamano H; Yanagi K; Takahashi M; Ishimaru N
Cell Immunol; 1996 Aug; 171(2):217-25. PubMed ID: 8806790
[TBL] [Abstract][Full Text] [Related]
27. Th17 cells play a critical role in the development of experimental Sjögren's syndrome.
Lin X; Rui K; Deng J; Tian J; Wang X; Wang S; Ko KH; Jiao Z; Chan VS; Lau CS; Cao X; Lu L
Ann Rheum Dis; 2015 Jun; 74(6):1302-10. PubMed ID: 24573745
[TBL] [Abstract][Full Text] [Related]
28. Activation of the extrinsic apoptotic pathway by TNF-alpha in human salivary gland (HSG) cells in vitro, suggests a role for the TNF receptor (TNF-R) and intercellular adhesion molecule-1 (ICAM-1) in Sjögren's syndrome-associated autoimmune sialadenitis.
Wang Y; Shnyra A; Africa C; Warholic C; McArthur C
Arch Oral Biol; 2009 Nov; 54(11):986-96. PubMed ID: 19716548
[TBL] [Abstract][Full Text] [Related]
29. The T cell in Sjogren's syndrome: force majeure, not spectateur.
Singh N; Cohen PL
J Autoimmun; 2012 Sep; 39(3):229-33. PubMed ID: 22709856
[TBL] [Abstract][Full Text] [Related]
30. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
[TBL] [Abstract][Full Text] [Related]
31. Bufotalin ameliorates experimental Sjögren's syndrome development by inhibiting Th17 generation.
Huang Y; Yang G; Fei J; Wu Y; Yan J
Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1977-1985. PubMed ID: 31950221
[TBL] [Abstract][Full Text] [Related]
32. RORγt antagonist improves Sjögren's syndrome-like sialadenitis through downregulation of CD25.
Ono Y; Tsuboi H; Moriyama M; Asashima H; Kudo H; Takahashi H; Honda F; Abe S; Kondo Y; Takahashi S; Matsumoto I; Nakamura S; Sumida T
Oral Dis; 2020 May; 26(4):766-777. PubMed ID: 31837283
[TBL] [Abstract][Full Text] [Related]
33. Blockade of CD40-CD154 pathway interactions suppresses ectopic lymphoid structures and inhibits pathology in the NOD/ShiLtJ mouse model of Sjögren's syndrome.
Wieczorek G; Bigaud M; Pfister S; Ceci M; McMichael K; Afatsawo C; Hamburger M; Texier C; Henry M; Cojean C; Erard M; Mamber N; Rush JS
Ann Rheum Dis; 2019 Jul; 78(7):974-978. PubMed ID: 30902822
[TBL] [Abstract][Full Text] [Related]
34. IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome.
Alunno A; Bistoni O; Bartoloni E; Caterbi S; Bigerna B; Tabarrini A; Mannucci R; Falini B; Gerli R
Ann Rheum Dis; 2013 Feb; 72(2):286-92. PubMed ID: 22904262
[TBL] [Abstract][Full Text] [Related]
35. Th17 cells in primary Sjögren's syndrome: Pathogenicity and plasticity.
Verstappen GM; Corneth OBJ; Bootsma H; Kroese FGM
J Autoimmun; 2018 Feb; 87():16-25. PubMed ID: 29191572
[TBL] [Abstract][Full Text] [Related]
36. Epithelial HLA-DR expression in labial salivary glands in Sjögren's syndrome and non-specific sialadenitis.
Speight PM; Cruchley A; Williams DM
J Oral Pathol Med; 1989 Mar; 18(3):178-83. PubMed ID: 2474646
[TBL] [Abstract][Full Text] [Related]
37. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder.
Gerli R; Muscat C; Giansanti M; Danieli MG; Sciuto M; Gabrielli A; Fiandra E; Vitali C
Br J Rheumatol; 1997 Sep; 36(9):969-75. PubMed ID: 9376993
[TBL] [Abstract][Full Text] [Related]
38. Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome.
Matsumoto I; Tsubota K; Satake Y; Kita Y; Matsumura R; Murata H; Namekawa T; Nishioka K; Iwamoto I; Saitoh Y; Sumida T
J Clin Invest; 1996 Apr; 97(8):1969-77. PubMed ID: 8621782
[TBL] [Abstract][Full Text] [Related]
39. The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sjögren's Syndrome.
Fonseca VR; Romão VC; Agua-Doce A; Santos M; López-Presa D; Ferreira AC; Fonseca JE; Graca L
Arthritis Rheumatol; 2018 May; 70(5):774-784. PubMed ID: 29361207
[TBL] [Abstract][Full Text] [Related]
40. Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjögren's syndrome.
Sumida T; Tsuboi H; Iizuka M; Nakamura Y; Matsumoto I
Autoimmun Rev; 2010 Jul; 9(9):615-7. PubMed ID: 20462524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
